Too Much of a Good Thing? Cancer Risk and High Dose Folic Acid in Epilepsy.
No abstract available
COI Statement
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References:
Pack AM, Oskoui M, Williams Roberson Set al. Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: Practice guideline from the AAN, AES, and SMFM. Neurology 2024;102(11):e209279.
Harden CL, Pennell PB, Koppel BSet al. American Academy of N, American Epilepsy S. Practice parameter update: Management issues for women with epilepsy–focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):142-149.
American Academy of Neurology Quality Standards Subcommittee Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1998;51(4):944-948.
Evidence reviews for high-dose folic acid supplementation before and during the first 12 weeks of pregnancy: Maternal and child nutrition: Evidence review A. London2025.
American Society for Reproductive Medicine Committee on Gynecologic Practice. AACOG Committee Opinion No. 762: Prepregnancy counseling. Obstet Gynecol 2019;133(1):e78-e89.